Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency

BACKGROUND: The hypercoagulability and thrombotic tendency in coronavirus disease 2019 (COVID-19) is multifactorial, driven mainly by inflammation, and endothelial dysfunction. Elevated levels of procoagulant microvesicles (MVs) and tissue factor–bearing microvesicles (TF-bearing MVs) have been obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamali, Hassan A, Saboor, Muhammad, Dobie, Gasim, Madkhali, Aymen M, Akhter, Mohammad S, Hakamy, Ali, Al-Mekhlafi, Hesham M, Jackson, Denise E, Matari, Yahya H, Mobarki, Abdullah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064482/
https://www.ncbi.nlm.nih.gov/pubmed/35517897
http://dx.doi.org/10.2147/IDR.S355395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064482/
https://www.ncbi.nlm.nih.gov/pubmed/35517897
http://dx.doi.org/10.2147/IDR.S355395

Ejemplares similares